Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Adalimumab biosimilar(Jiangsu Chia-tai Tianqing Pharmaceutical Co. Ltd.) in Pediatric Crohn's Disease: NCT07564505 Clinical Landscape Report 2026
28 September 2026
NCT07564505 clinical landscape for Pediatric Crohn's Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ethinyl Estradiol/Norethindrone Acetate/Ferrous Fumarate in Diabetes Insipidus: NCT07568509 Clinical Landscape Report 2026
28 September 2026
NCT07568509 clinical landscape for Diabetes Insipidus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CRPA1A2 in Hepatocellular Carcinoma: NCT07583316 Clinical Landscape Report 2026
28 September 2026
NCT07583316 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Infliximab in Colitis, Ulcerative: NCT07576452 Clinical Landscape Report 2026
28 September 2026
NCT07576452 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Amifostine in Hepatocellular Carcinoma: NCT07580261 Clinical Landscape Report 2026
28 September 2026
NCT07580261 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Leucovorin Calcium in Hepatocellular Carcinoma: NCT07594964 Clinical Landscape Report 2026
28 September 2026
NCT07594964 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
18F-FD4 in Multiple System Atrophy: NCT07604116 Clinical Landscape Report 2026
28 September 2026
NCT07604116 clinical landscape for Multiple System Atrophy: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apomorphine Hydrochloride in Nervous System Diseases: PACTR202605760621936 Clinical Landscape Report 2026
28 September 2026
PACTR202605760621936 clinical landscape for Nervous System Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Erdosteine in Pulmonary Disease, Chronic Obstructive: CTRI/2026/05/110935 Clinical Landscape Report 2026
28 September 2026
CTRI/2026/05/110935 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and developm…
9 min read
Leucovorin Calcium in Locally Advanced Cholangiocarcinoma: NCT07619313 Clinical Landscape Report 2026
28 September 2026
NCT07619313 clinical landscape for Locally Advanced Cholangiocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
LT-010391 in Pancreatic Ductal Adenocarcinoma: NCT07624214 Clinical Landscape Report 2026
28 September 2026
NCT07624214 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Mirikizumab in Inflammatory Bowel Diseases: NCT07612267 Clinical Landscape Report 2026
28 September 2026
NCT07612267 clinical landscape for Inflammatory Bowel Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.